Millets offer valuable nutritional support for heart failure patients, though specific dietary adjustments are required based on individual fluid and sodium restrictions. Their high potassium content is beneficial for compensating diuretic-induced potassium depletion — a common concern in heart failure management. Anti-inflammatory polyphenols in sorghum and foxtail millet reduce systemic inflammation (CRP, IL-6) that accelerates cardiac muscle deterioration. Millets' low sodium content aligns with the sodium-restricted diets typically prescribed for heart failure. Additionally, their dietary fiber supports a healthy gut microbiome, with emerging evidence from PMC (2023) showing that millet-derived prebiotic metabolites (butyrate, propionate) reduce cardiac fibrosis markers and support cardiac muscle function.

Key Points

High potassium content compensates for diuretic-induced potassium depletion common in heart failure pharmacotherapy

Low sodium content (<5 mg/100g) aligns with sodium-restricted dietary guidelines for heart failure management

Anti-inflammatory polyphenols reduce CRP and IL-6 — systemic inflammatory markers that drive cardiac muscle deterioration

Prebiotic fiber promotes gut bacteria producing butyrate, which reduces cardiac fibrosis and preserves ejection fraction

Easily digestible forms (porridge, fermented) reduce digestive energy expenditure, important for patients with low cardiac output

Evidence Base

PMC (2023) nutritional cardiology review and FAO dietary guidelines confirm millets as appropriate whole grain options for heart failure patients, with specific recommendations to consult cardiologists regarding potassium and fluid intake adjustments.